Insider Transactions in Q3 2022 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$128,000
$16.67 P/Share
|
|
Sep 15
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.78%
|
$80,000
$16.03 P/Share
|
|
Sep 14
2022
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
18,400
+50.0%
|
$294,400
$16.16 P/Share
|
|
Sep 14
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.75%
|
$144,000
$16.01 P/Share
|
|
Aug 24
2022
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,188
+4.34%
|
$25,940
$5.72 P/Share
|
|
Aug 18
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.22%
|
$80,000
$16.3 P/Share
|
|
Aug 17
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.33%
|
$128,000
$16.97 P/Share
|
|
Aug 15
2022
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
3,749
+31.65%
|
-
|
|
Aug 15
2022
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-25.0%
|
-
|